These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2466331)

  • 1. Pregnant women's attitudes for accepting or declining a serum-alpha-fetoprotein test.
    Sandén ML; Bjurulf P
    Scand J Soc Med; 1988; 16(4):265-71. PubMed ID: 2466331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pregnant women's attitudes and knowledge in relation to access to serum-alpha-fetoprotein test.
    Sandén ML; Bjurulf P
    Scand J Soc Med; 1988; 16(4):197-204. PubMed ID: 2466330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attitudes to prenatal screening, diagnosis and research among pregnant women who accept or decline an alpha-fetoprotein test.
    Jørgensen FS
    Prenat Diagn; 1995 May; 15(5):419-29. PubMed ID: 7543997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors affecting the uptake of screening for neural tube defect.
    Kyle D; Cummins C; Evans S
    Br J Obstet Gynaecol; 1988 Jun; 95(6):560-4. PubMed ID: 2455536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Declining an alpha-fetoprotein test in pregnancy, why and who?
    Jørgensen FS
    Acta Obstet Gynecol Scand; 1995 Jan; 74(1):3-11. PubMed ID: 7531936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Who declines from antenatal serum alpha-fetoprotein screening--and why?
    Berne-Fromell K; Josefson G; Kjessler B
    Acta Obstet Gynecol Scand; 1984; 63(8):687-91. PubMed ID: 6084392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Attitude of pregnant women to prenatal screening].
    Jørgensen FS
    Ugeskr Laeger; 1996 Sep; 158(39):5447-52. PubMed ID: 8928256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Women's opinions on the offer and use of prenatal diagnosis.
    Tymstra TJ; Bajema C; Beekhuis JR; Mantingh A
    Prenat Diagn; 1991 Dec; 11(12):893-8. PubMed ID: 1725210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 'Collective fictions': similarities in reasons for accepting maternal serum alpha-fetoprotein screening among women of diverse ethnic and social class backgrounds.
    Press NA; Browner CH
    Fetal Diagn Ther; 1993 Apr; 8(Suppl. 1):97-106. PubMed ID: 11653028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Women's attitudes to screening for neural tube defects.
    Bennett MJ; Gau GS; Gau DW
    Br J Obstet Gynaecol; 1980 May; 87(5):370-1. PubMed ID: 6155931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What participants understand about a maternal serum alpha-fetoprotein screening program.
    Faden RR; Chwalow AJ; Orel-Crosby E; Holtzman NA; Chase GA; Leonard CO
    Am J Public Health; 1985 Dec; 75(12):1381-4. PubMed ID: 2415009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reasons for accepting or declining Down syndrome screening in Dutch prospective mothers within the context of national policy and healthcare system characteristics: a qualitative study.
    Crombag NM; Boeije H; Iedema-Kuiper R; Schielen PC; Visser GH; Bensing JM
    BMC Pregnancy Childbirth; 2016 May; 16(1):121. PubMed ID: 27229318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasound scanning in women with raised serum alpha fetoprotein: short term psychological effect.
    Tsoi MM; Hunter M; Pearce M; Chudleigh P; Campbell S
    J Psychosom Res; 1987; 31(1):35-9. PubMed ID: 2434650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethnicity, bioethics, and prenatal diagnosis: the amniocentesis decisions of Mexican-origin women and their partners.
    Browner CH; Preloran HM; Cox SJ
    Am J Public Health; 1999 Nov; 89(11):1658-66. PubMed ID: 10553385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Women's decision-making in prenatal screening.
    Santalahti P; Hemminki E; Latikka AM; Ryynänen M
    Soc Sci Med; 1998 Apr; 46(8):1067-76. PubMed ID: 9579758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of prenatal screening and diagnostic testing upon the cognitions, emotions and behaviour of pregnant women.
    Marteau TM; Johnston M; Shaw RW; Michie S; Kidd J; New M
    J Psychosom Res; 1989; 33(1):7-16. PubMed ID: 2466994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. User acceptability of an alpha-fetoprotein screening programme.
    Jørgensen FS
    Dan Med Bull; 1995 Feb; 42(1):100-5. PubMed ID: 7537190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient attitudes toward testing for maternal serum alpha-fetoprotein values when results are false-positive or true-negative.
    Earley KJ; Blanco JD; Prien S; Willis D
    South Med J; 1991 Apr; 84(4):439-42. PubMed ID: 1707553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A meta-synthesis of pregnant women's decision-making processes with regard to antenatal screening for Down syndrome.
    Reid B; Sinclair M; Barr O; Dobbs F; Crealey G
    Soc Sci Med; 2009 Dec; 69(11):1561-73. PubMed ID: 19783085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.